Seelos Therapeutics Inc (SEEL)
0.3215
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 10:38
Seelos Therapeutics Free Cash Flow (Quarterly): -1.911M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.911M |
| September 30, 2023 | -5.749M |
| June 30, 2023 | -5.904M |
| March 31, 2023 | -10.35M |
| December 31, 2022 | -13.09M |
| September 30, 2022 | -11.07M |
| June 30, 2022 | -20.40M |
| March 31, 2022 | -17.04M |
| December 31, 2021 | -18.34M |
| September 30, 2021 | -10.51M |
| June 30, 2021 | -8.894M |
| March 31, 2021 | -11.25M |
| December 31, 2020 | -3.329M |
| September 30, 2020 | -4.18M |
| June 30, 2020 | -6.981M |
| March 31, 2020 | -6.423M |
| December 31, 2019 | -5.118M |
| September 30, 2019 | -2.91M |
| June 30, 2019 | -3.337M |
| March 31, 2019 | -7.94M |
| December 31, 2018 | -6.945M |
| September 30, 2018 | 2.684M |
| June 30, 2018 | -1.94M |
| March 31, 2018 | -1.928M |
| December 31, 2017 | -2.473M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.028M |
| June 30, 2017 | -2.269M |
| March 31, 2017 | -2.696M |
| December 31, 2016 | -2.705M |
| September 30, 2016 | -0.861M |
| June 30, 2016 | -3.249M |
| March 31, 2016 | -6.271M |
| December 31, 2015 | -1.431M |
| September 30, 2015 | -6.622M |
| June 30, 2015 | -8.634M |
| March 31, 2015 | -6.292M |
| December 31, 2014 | -9.198M |
| September 30, 2014 | -4.145M |
| June 30, 2014 | -4.705M |
| March 31, 2014 | -0.547M |
| December 31, 2013 | 0.553M |
| September 30, 2013 | -4.21M |
| June 30, 2013 | -5.172M |
| March 31, 2013 | -6.809M |
| December 31, 2012 | -3.148M |
| September 30, 2012 | -2.901M |
| June 30, 2012 | -3.589M |
| March 31, 2012 | -5.18M |
| December 31, 2011 | -2.489M |
| September 30, 2011 | -2.812M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-20.40M
Minimum
Jun 2022
-1.911M
Maximum
Dec 2023
-8.778M
Average
-6.981M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| 180 Life Sciences Corp | -2.16M |
| Acurx Pharmaceuticals Inc | -4.198M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |